This week's report explores the pharmaceutical industry’s evolution toward resilient, scalable systems that prioritize ...
Blau Farmacêutica, a Brazilian pharmaceutical company listed on Brazilian Stock Market and a regional leader in hospital ...
The results of the phase 3 MajesTEC-9 trial showcase teclistamab's efficacy for patients with relapsed/refractory multiple ...
Kiniksa (KNSA) shifts from survival to growth as Arcalyst nears blockbuster sales and pipeline KPL-387 readouts loom—get the ...
Berger has participated in meetings (lectures, advisory boards, consultations) sponsored and compensated by pharmaceutical ...
Two-year real-world data highlight strong drug survival and effectiveness of bimekizumab in plaque psoriasis. Learn more ...
To this day, animal testing remains one of the most controversial issues in animal rights. Activists have been fighting ...
By CH Unnikrsihnan Drug maker and researcher Glenmark Pharmaceuticals Ltd's new biological drug candidate Bi-Specific ...
January 23, 2026 Following the positive COAST 1 results in September 2025, two additional global Phase III studies – SHORE and COAST 2 of amlitelimab, a fully human non-T cell depleting monoclonal ...
The panel discussion, “Innovations in Breast Cancer Treatment,” examined the challenge of maintaining or increasing access to care as breast cancer treatment becomes more stratified through biomarker ...
More than 140 U.S. medical organizations are advocating for the passage of a bill that would increase NIH funding for fiscal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results